Approaches for Lung Fiducial Markers Insertion in Stereotactic Body Radiotherapy: A Systematic Review and Meta-Analysis

🩺 Clinical Context

Stereotactic Body Radiotherapy (SBRT) is the standard of care for medically inoperable early-stage NSCLC. Precise tumor localization is paramount to minimize the “margin of error” and spare healthy lung parenchyma. Fiducial marker placement—often performed by Interventional Pulmonologists (IP) via bronchoscopy—is a critical procedural step. This systematic review and meta-analysis synthesize the heterogeneous data regarding insertion techniques (e.g., electromagnetic navigation bronchoscopy (ENB), radial EBUS, CT-guided) to determine which approach offers the best balance of diagnostic yield, marker retention, and safety profile (specifically pneumothorax rates).

📊 Methodological Strengths & Weaknesses

Strengths:

• Comprehensive Synthesis: The study aggregates data across multiple modalities, providing a necessary “bird’s-eye view” of the current landscape in a field often dominated by single-center retrospective series.
• Clinical Relevance: By focusing on both technical success (marker placement) and clinical outcomes (pneumothorax, migration), it addresses the primary concerns of the IP attending.

Weaknesses:

• Heterogeneity of Data: The included studies vary significantly in terms of tumor location (peripheral vs. central), patient comorbidities (COPD/emphysema), and the specific type of fiducial marker used (e.g., gold coils vs. hydrogel-based markers), which limits the ability to draw a “one-size-fits-all” conclusion.
• Publication Bias: As with many procedural meta-analyses, there is a risk of reporting bias where high-volume centers with superior outcomes are overrepresented, potentially underestimating the complication rates in lower-volume or community settings.
• Lack of Standardization: The definition of “success” and “complication” (e.g., what constitutes a clinically significant pneumothorax requiring intervention) is not uniform across the source literature, complicating the meta-analysis.

💡 Takeaway for Fellows

1. Know Your Modality: While ENB and radial EBUS are standard, the choice of guidance should be dictated by the lesion’s location and the presence of a bronchus sign. If the lesion is sub-centimeter or lacks a clear bronchus sign, the risk of pneumothorax increases significantly, and you must have a low threshold for prophylactic measures or alternative planning.
2. The “Pneumothorax” Reality Check: Don’t be misled by low complication rates in literature. In your practice, patient selection (specifically the degree of underlying emphysema) is the strongest predictor of a post-procedural chest tube. Always review the CT for bullous disease near the target path.
3. Marker Migration: Be aware that marker migration is a real, albeit under-reported, phenomenon. Ensure the marker is deployed deep enough within the lesion or in the immediate peritumoral tissue to prevent displacement during respiratory motion or coughing.
4. Multidisciplinary Planning: This study reinforces that the “best” approach is the one that minimizes the number of passes. Coordinate closely with your Radiation Oncology colleagues—they need the marker to be visible and stable; you need the procedure to be safe. If you can’t hit it safely, don’t force it; discuss CT-guided options with Interventional Radiology.